RAPT Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
RAPT Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • RAPT Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.38M, a 27% increase year-over-year.
  • RAPT Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $19.5M, a 37.4% increase year-over-year.
  • RAPT Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17.1M, a 51.7% increase from 2022.
  • RAPT Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.3M, a 13.2% increase from 2021.
  • RAPT Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.95M, a 14.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17.1M +$5.83M +51.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $11.3M +$1.31M +13.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $9.95M +$1.27M +14.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $8.69M +$6.64M +324% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $2.05M +$881K +75.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $1.17M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.